Quantification of prevalence of asymptomatic ventricular arrhythmias in patients with heart failure

Annals of Noninvasive Electrocardiology

Volumn 2, Issue 4, 1997, Pages 346-352

  Anastasiou Nana, Maria I ^a   Menlove, Ronald L ^b   Mason, Jay W ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chronic heart failure; Prevalence of ventricular arrhythmias; Ventricular arrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030694056     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474x.1997.tb00199.x     Document Type: Article

References (35)

1. Meinertz T, Hofmann T, Kasper W, et al. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1984;53:902-907.
2. Holmes J, Kubo SH, Cody RJ, et al. Arrhythmias in ischémie and nonischemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985;55:146-151.
3. Olshaussen K, Schafer A, Mehmel HC, et al. Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 1984;51:195-201.
4. Huang SK, Messer JV, Deves P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients. Am J Cardiol 1983;51:507-512.
5. Maskin CS, Siskind SJ, Lejemtel TH. High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart] 1984; 107:896-901.
6. Francis GS. Development of arrhythmias in the patient with congestive heart failure: Pathophysiology, prevalence and prognosis. Am J Cardiol 1986;57:3B-7B.
7. Parmley WW, Chatterjee K. Congestive heart failure and arrhythmias: An overview. Am J Cardiol 1986;57:34B-37B.
8. Szabo BM, van-Veldhuisen DJ, Crijns HJ, et al. Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure. Eur Heart] 1994;15(7):928933.
9. Wilson JR, Schwartz JS, Sutton M, et al. Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983;2:403410.
10. Emanuelsson H, Karlson BW, Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J 1994; 15(6):761-768.
11. Luu M, Stevenson WG, Stevenson LVV, et al. Diverse mechanisms of unsuspected cardiac arrest in advanced heart failure. Circulation 1989;80:1675-1680.
12. Dean JW, Lab MJ. Arrhythmia in heart failure: Role of mechanically induced changes in electrophysiology. Lancet 1989;8650:1309-1312.
13. Pogwizd SM. Focal mechanisms underlying ventricular tachycardia during prolonged ischémie cardiomyopathy. Circulation 1994;90(3):1441-1458.
14. Moss AJ, Davis HT, Conard DL, et al. Digitalis-associated cardiac mortality after myocardial infarction. Circulation 1981;64:1150-1156.
15. Bigger JT Jr, Fleiss JL, Rolnitzky LM, et al. Effect of digitalis treatment on survival after acute myocardial infarction. Am J Cardiol 1985;55:623-630.
16. Moss AJ. Risk stratification and survival after myocardial infarction. The multicenter postinfarction research group. N Engl J Med 1983;309|6):331-336.
17. Bigger JT Jr, Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69(2):250-258.
18. Hallstrom A, Pratt CM, Greene HL, et al. Relation between heart failure, ejection fraction, arrhythmia suppression and mortality: Analysis of the Cardiac Arrhythmia Suppression Trial. J Am Coll Cardiol 1995;25(6):1250-1257.
19. Gottlieb SS. The use of antiarrhythmic agents in heart failure: Implications of CAST. Am Heart J 1989; 118:10741077.
20. Francis GS. Should asymptomatic ventricular arrhythmias in patients with congestive heart failure be treated with antiarrhythmic drugs? J Am Coll Cardiol 1988; 12:274-283.
21. Chakko CS, Gheorghiade M. Ventricular arrhythmias in se vere heart failure: Incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J 1985; 109:497-504.
22. Kottkamp H, Budde T, Lamp B, et al. Clinical significance and management of ventricular arrhythmias in heart failure. Eur Heart] 1994; 15|Suppl D):155-163.
23. Garguichevich JJ, Ramos JL, Gambarte A, et al. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). Am Heart] 1995; 130(3 Pt.l):494500.
24. Singh BN. Expanding indications for the use of class agents in patients at high risk for sudden death. J Cardiovasc Electrophysiol 1995;6(10 Pt 2):887-900.
25. Echt DS, Liebson PR, the CAST Investigators, et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;325:781-788.
26. Anastasiou-Nana MI, Menlove RL, Nanas JN, et al. Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias. Circulation 1988;78:286-295.
27. Anderson JL, Anastasiou-Nana MI , Menlove RL, et al. Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy. Circulation 1990; 82: 830-840.
28. Anastasiou-Nana MI, Menlove RL, Nanas JN, et al. for the Western Enoximone Study Group. Spontaneous variability of ventricular arrhythmias in patients with chronic heart failure. Am Heart J 1991; 122:1007-1015.
29. Moss AJ, Jackson H, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
30. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population. Chest 1982;81:302-307.
31. Kostis JB, McCrone K, Moreyra AE, et al. Premature ventricular complexes in the absence of identifiable heart disease. Circulation 1981;63:1351-1356.
32. Gilbert EM, Bristow MR, Mason JW. Acute hemodynamic response to low dose enoximone (MDL 17,043): An oral dose-range study. Am J Cardiol 1987;60:57C-62C.
33. Treese N, Erbel R, Pilcher J, et al. Long-term treatment with oral enoximone for chronic congestive heart failure: The European experience. Am J Cardiol 1987;60:85C-90C.
34. Zipperle G, Butzer F, Dieterich HA, et al. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure. Am J Cardiol 1987;60:72C74C.
35. Narahara KA and the Western Enoximone Study Group. Oral enoximone therapy in chronic heart failure: A placebocontrolled randomized trial. Am Heart J 1991; 121:14711479.